TRUVERIS NATIONAL DRUG INDEX
Dead / Cancelled — Cancelled — Section 8 (as of 13 Oct 2023)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86528944
- Registration number
- 5172037
- Mark type
- Stylized text
- Filed
- 09 Feb 2015
- Published for opposition
- 03 Nov 2015
- Registered
- 28 Mar 2017
- Attorney of record
- Edmund J. Ferdinand, III
Goods and services
- Class 035 — Advertising and business services: Business research services in the field of prescription drug pricing. Conducting business research, compiling and analyzing statistics, data and other sources of information for business purposes and conducting analysis of market research data and statistics all with respect to periodic fluctuations in drug prices of pharmaceutical manufacturers and pharmaceutical drug spending of patients as an index of pharmaceutical industry growth
Owner
- TRUVERIS, INC., New York, NY, US
- TRUVERIS, INC., New York, NY, US
- TRUVERIS, INC., New York, NY, US
Prosecution history
- 13 Oct 2023 — CANCELLED SEC. 8 (6-YR)
- 28 Mar 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 04 Feb 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 04 Feb 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 28 Mar 2017 — REGISTERED-PRINCIPAL REGISTER
- 22 Feb 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 Feb 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Jan 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 11 Jan 2017 — USE AMENDMENT FILED
- 28 Jan 2017 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Jan 2017 — TEAS STATEMENT OF USE RECEIVED
- 11 Jan 2017 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 13 Aug 2016 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Aug 2016 — SOU EXTENSION 1 GRANTED
- 11 Aug 2016 — SOU EXTENSION 1 FILED